- Home
- TACT vs LVTX Comparison
TACT vs LVTX Comparison
Compare TACT & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TACT
- LVTX
- Stock Information
- Founded
- TACT 1996
- LVTX 2016
- Country
- TACT United States
- LVTX Netherlands
- Employees
- TACT N/A
- LVTX N/A
- Industry
- TACT Computer peripheral equipment
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- TACT Technology
- LVTX Health Care
- Exchange
- TACT Nasdaq
- LVTX Nasdaq
- Market Cap
- TACT 42.2M
- LVTX 41.3M
- IPO Year
- TACT 1996
- LVTX 2021
- Fundamental
- Price
- TACT $4.46
- LVTX $1.57
- Analyst Decision
- TACT Strong Buy
- LVTX Hold
- Analyst Count
- TACT 1
- LVTX 4
- Target Price
- TACT $5.00
- LVTX $1.58
- AVG Volume (30 Days)
- TACT 61.9K
- LVTX 157.8K
- Earning Date
- TACT 08-06-2025
- LVTX 08-13-2025
- Dividend Yield
- TACT N/A
- LVTX N/A
- EPS Growth
- TACT N/A
- LVTX N/A
- EPS
- TACT N/A
- LVTX N/A
- Revenue
- TACT $47,949,000.00
- LVTX $4,990,000.00
- Revenue This Year
- TACT $21.67
- LVTX N/A
- Revenue Next Year
- TACT $7.63
- LVTX N/A
- P/E Ratio
- TACT N/A
- LVTX N/A
- Revenue Growth
- TACT N/A
- LVTX N/A
- 52 Week Low
- TACT $3.12
- LVTX $0.85
- 52 Week High
- TACT $4.89
- LVTX $2.09
- Technical
- Relative Strength Index (RSI)
- TACT 64.16
- LVTX 61.88
- Support Level
- TACT $4.09
- LVTX $1.53
- Resistance Level
- TACT $4.51
- LVTX $1.57
- Average True Range (ATR)
- TACT 0.20
- LVTX 0.04
- MACD
- TACT 0.01
- LVTX -0.00
- Stochastic Oscillator
- TACT 59.42
- LVTX 78.48
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.